Barriers and Enablers of Healthcare Providers to Deprescribe Cardiometabolic Medication in Older Patients: A Focus Group Study

202272 citationsJournal Articlehybrid Open Access

Authors

Jamila Abou · Amsterdam Neuroscience

Stijn Crutzen · University Medical Center Groningen

Vashti N. M. F. Tromp · Amsterdam University Medical Centers

Mette Heringa · Utrecht University

Rob J. van Marum · Amsterdam Public Health

Petra J. M. Elders · Amsterdam University Medical Centers

Katja Taxis

Abstract

HCPs recognized the importance of deprescribing cardiometabolic medication as a medical decision that can only be made in close cooperation with the patient. To successfully accomplish the process of deprescribing they strongly recommended a multidisciplinary approach.

Topics & Keywords

Pharmaceutical Practices and Patient Outcomes Medication Adherence and Compliance Health Systems, Economic Evaluations, Quality of Life

Publication Details

Published in: Drugs & Aging

Volume 39, Issue 3, pp. 209-221

DOI: 10.1007/s40266-021-00918-7

Field-Weighted Citation Impact: 8.92

Command Palette

Barriers and Enablers of Healthcare Providers to Deprescribe Cardiometabolic Medication in Older Patients: A Focus Group Study

Authors

Abstract

Topics & Keywords

Publication Details